3,4-metylendioksyamfetamin (Danish Wikipedia)

Analysis of information sources in references of the Wikipedia article "3,4-metylendioksyamfetamin" in Danish language version.

refsWebsite
Global rank Danish rank
4th place
24th place
2nd place
13th place
low place
low place
1st place
1st place
low place
low place
18th place
119th place
621st place
5,663rd place
14th place
37th place
low place
low place
11th place
291st place

archive.today

doi.org

  • Crean, R. D.; Davis, S. A.; Von Huben, S. N.; Lay, C. C.; Katner, S. N.; Taffe, M. A. (2006-10-13). "Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques". Neuroscience. 142 (2): 515-525. doi:10.1016/j.neuroscience.2006.06.033. PMC 1853374. PMID 16876329.
  • de la Torre, R; Farre, M; Roset, Pn; Pizzaro, N; Abanades, S; Segura, M; Segura, M; Camí, J (2004). "Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition". Therapeutic Drug Monitoring. 26 (2): 137-144. doi:10.1097/00007691-200404000-00009. PMID 15228154.
  • Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (1993). "Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine". Journal of Medicinal Chemistry. 36 (23): 3700-3706. doi:10.1021/jm00075a027. PMID 8246240.
  • Baggott, MJ; Siegrist, JD; Galloway, GP; Robertson, LC; Coyle, JR; Mendelson, JE (2010). "Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxeamphetamine (MDA): A Randomized Controlled Trial in Humans". PLOS ONE. 5 (12): e14074. Bibcode:2010PLoSO...514074B. doi:10.1371/journal.pone.0014074. PMC 2996283. PMID 21152030.
  • Mannich, C.; Jacobsohn, W.; Mannich, Hr. C. (1910). "Über Oxyphenyl-alkylamine und Dioxyphenyl-alkylamine". Berichte der Deutschen Chemischen Gesellschaft. 41 (1): 189-197. doi:10.1002/cber.19100430126.
  • Naranjo, C.; Shulgin, A. T.; Sargent, T. (1967). "Evaluation of 3, 4-methylenedioxeamphetamine (MDA) as an adjunct to psychotherapy". Pharmacology. 17 (4): 359-364. doi:10.1159/000137100. PMID 5631047.
  • Yensen, R.; Di Leo, F. B.; Rhead, J. C.; Richards, W. A.; Soskin, R. A.; Turek, B.; Kurland, A. A. (1976). "MDA-assisted psychotherapy with neurotic outpatients: a pilot study". The Journal of Nervous and Mental Disease. 163 (4): 233-245. doi:10.1097/00005053-197610000-00002. PMID 972325. S2CID 41155810.

ecstasydata.org

harvard.edu

ui.adsabs.harvard.edu

idpc.net

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Crean, R. D.; Davis, S. A.; Von Huben, S. N.; Lay, C. C.; Katner, S. N.; Taffe, M. A. (2006-10-13). "Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques". Neuroscience. 142 (2): 515-525. doi:10.1016/j.neuroscience.2006.06.033. PMC 1853374. PMID 16876329.
  • de la Torre, R; Farre, M; Roset, Pn; Pizzaro, N; Abanades, S; Segura, M; Segura, M; Camí, J (2004). "Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition". Therapeutic Drug Monitoring. 26 (2): 137-144. doi:10.1097/00007691-200404000-00009. PMID 15228154.
  • Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (1993). "Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine". Journal of Medicinal Chemistry. 36 (23): 3700-3706. doi:10.1021/jm00075a027. PMID 8246240.
  • Baggott, MJ; Siegrist, JD; Galloway, GP; Robertson, LC; Coyle, JR; Mendelson, JE (2010). "Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxeamphetamine (MDA): A Randomized Controlled Trial in Humans". PLOS ONE. 5 (12): e14074. Bibcode:2010PLoSO...514074B. doi:10.1371/journal.pone.0014074. PMC 2996283. PMID 21152030.
  • Naranjo, C.; Shulgin, A. T.; Sargent, T. (1967). "Evaluation of 3, 4-methylenedioxeamphetamine (MDA) as an adjunct to psychotherapy". Pharmacology. 17 (4): 359-364. doi:10.1159/000137100. PMID 5631047.
  • Yensen, R.; Di Leo, F. B.; Rhead, J. C.; Richards, W. A.; Soskin, R. A.; Turek, B.; Kurland, A. A. (1976). "MDA-assisted psychotherapy with neurotic outpatients: a pilot study". The Journal of Nervous and Mental Disease. 163 (4): 233-245. doi:10.1097/00005053-197610000-00002. PMID 972325. S2CID 41155810.

ncbi.nlm.nih.gov

  • Crean, R. D.; Davis, S. A.; Von Huben, S. N.; Lay, C. C.; Katner, S. N.; Taffe, M. A. (2006-10-13). "Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques". Neuroscience. 142 (2): 515-525. doi:10.1016/j.neuroscience.2006.06.033. PMC 1853374. PMID 16876329.
  • Baggott, MJ; Siegrist, JD; Galloway, GP; Robertson, LC; Coyle, JR; Mendelson, JE (2010). "Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxeamphetamine (MDA): A Randomized Controlled Trial in Humans". PLOS ONE. 5 (12): e14074. Bibcode:2010PLoSO...514074B. doi:10.1371/journal.pone.0014074. PMC 2996283. PMID 21152030.

psychedelicresearch.org

semanticscholar.org

api.semanticscholar.org

  • Yensen, R.; Di Leo, F. B.; Rhead, J. C.; Richards, W. A.; Soskin, R. A.; Turek, B.; Kurland, A. A. (1976). "MDA-assisted psychotherapy with neurotic outpatients: a pilot study". The Journal of Nervous and Mental Disease. 163 (4): 233-245. doi:10.1097/00005053-197610000-00002. PMID 972325. S2CID 41155810.

web.archive.org

zenodo.org